Geneos Wealth Management’s FIVE9 FIVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.13K Hold
100
﹤0.01% 2315
2026
Q1
$1.52K Hold
100
﹤0.01% 2353
2025
Q4
$2K Hold
100
﹤0.01% 2316
2025
Q3
$2.42K Sell
100
-87
-47% -$2.3K ﹤0.01% 2290
2025
Q2
$4.95K Sell
187
-64
-25% -$1.67K ﹤0.01% 2582
2025
Q1
$6.82K Buy
251
+64
+34% +$2.35K ﹤0.01% 2408
2024
Q4
$7.6K Sell
187
-12
-6% -$433 ﹤0.01% 2170
2024
Q3
$5.72K Buy
199
+99
+99% +$3.57K ﹤0.01% 2032
2024
Q2
$4.41K Hold
100
﹤0.01% 1749
2024
Q1
$6.21K Hold
100
﹤0.01% 1669
2023
Q4
$7.87K Hold
100
﹤0.01% 1604
2023
Q3
$6.43K Hold
100
﹤0.01% 1672
2023
Q2
$8.24K Sell
100
-70
-41% -$4.7K ﹤0.01% 1624
2023
Q1
$12.3K Hold
170
﹤0.01% 1493
2022
Q4
$11.5K Sell
170
-50
-23% -$3.14K ﹤0.01% 1492
2022
Q3
$16K Hold
220
﹤0.01% 1388
2022
Q2
$20K Hold
220
﹤0.01% 1678
2022
Q1
$24K Hold
220
﹤0.01% 1711
2021
Q4
$30K Hold
220
﹤0.01% 1694
2021
Q3
$36K Hold
220
﹤0.01% 1648
2021
Q2
$41K Buy
+220
New +$37.9K ﹤0.01% 1571

Other funds holding FIVN

Geneos Wealth Management's FIVN Position: Q2 2026 in Review

Geneos Wealth Management held its FIVE9 (FIVN) position steady in Q2 2026 at 100 shares worth $2.13K. The position accounts for ﹤0.01% of the portfolio, ranked #2315.

Geneos Wealth Management first reported a position in FIVN in Q2 2021 and has held it in 21 quarters since. The position peaked at $41K in Q2 2021. 293 funds tracked by Wall St. Rank hold FIVN as of Q2 2026.

  • Geneos Wealth Management held 100 shares of FIVE9 worth $2.13K as of Q2 2026.
  • Geneos Wealth Management left its FIVE9 share count unchanged in Q2 2026.
  • FIVE9 made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2315 holding.
  • Geneos Wealth Management first reported a position in FIVE9 in Q2 2021 and has held it in 21 quarters since.
  • Geneos Wealth Management's FIVE9 position peaked at $41K in Q2 2021.
  • 293 funds tracked by Wall St. Rank held FIVE9 as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.